Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
28.99
+0.03 (0.10%)
At close: Nov 26, 2025, 4:00 PM EST
28.98
-0.01 (-0.03%)
After-hours: Nov 26, 2025, 4:30 PM EST
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 77 employees as of December 31, 2024. The number of employees increased by 1 or 1.32% compared to the previous year.
Employees
77
Change (1Y)
1
Growth (1Y)
1.32%
Revenue / Employee
$194,805
Profits / Employee
-$3,151,922
Market Cap
4.23B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CNTA News
- 10 days ago - Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - The Motley Fool
- 14 days ago - Why Centessa Pharmaceuticals Stock Crushed the Market Today - The Motley Fool
- 15 days ago - Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares - GlobeNewsWire
- 16 days ago - Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares - GlobeNewsWire
- 20 days ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 22 days ago - Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program - GlobeNewsWire
- 3 months ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 - GlobeNewsWire